CELLULITIS IN PATIENTS WITH DIABETIC FOOT DISEASE
June 22, 2020
MANAGEMENT OF CELLULITIS ASSOCIATED WITH ACTIVE ULCERATION IN PATIENTS WITH DIABETIC FOOT DISEASE
Over the last 12 months POAC claims have been made in seven cases where IV antibiotics were administered to patients with active diabetic foot ulceration who have then required hospital admission. Five of these admissions resulted in amputation.
POAC aligns its funding...
TSANZ statement on nebuliser use during Covid-19
April 10, 2020
Peak Respiratory Bodies recommend the use of spacers rather than nebulisers during the SARS CoV-2 pandemic
Novel coronavirus disease 2019 (COVID-19) is an infectious disease caused by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its identification in December 2019, COVID-19 has spread internationally and was declared a Public Health Emerg...
INR monitoring during Covid-19
March 31, 2020
Outpatient INR monitoring for patients receiving warfarin during COVID-19 pandemic.
Outpatient INR monitoring for patients receiving warfarin during COVID-19 pandemic.
The need for regular INR testing among patients receiving warfarin to achieve safe anticoagulation is difficult during this time of “social distancing” to minimise the risk of spreading t...
COVID-19 TESTING CENTRE LOCATIONS
March 23, 2020
Open 7 days, 8am - 4pm
Counties Medical , 106 Great South Rd, Takanini (09) 299 7670ETHC Airport Oaks, 149a Kirkbride Rd, Mangere (09) 275 1202Whitecross St Lukes, 52 St Lukes Rd, Mt Albert (09) 815 3111Henderson Specialist Centre, 31 Lincoln Rd, Henderson Shorecare Northcross,...
COVID-19 FUNDING
March 23, 2020
The e-Notification via Care Connect should be used to submit all Covid-19 notifications to Auckland Regional Public Health Service.
Reimbursement for activity is based on the patient paying no co-payment and is to be applied regardless ...
CXR UNDER POAC FOR LOWER RESPIRATORY TRACT INFECTION
March 19, 2020
In light of the current COVID – 19 pandemic POAC would like to take the opportunity to reinforce the POAC funding policy for CXR in Community Acquired Pneumonia (CAP).
In accordance with the Auckland Regional HealthPathway for Community Acquired Pneumonia in Adults
Chest X...
The ultrasound DVT pathway has been updated to include a stat dose of 15mg oral Rivaroxaban where there is a delay >6 hours to ultrasound. This is an alternative to administering Clexane.
Ensure to check contraindications and cautions - see link here for the Ultrasou...
Top tips for adult dehydration management
February 18, 2020
POAC only funds dehydration cases for moderate dehydration with vomiting and must include a trial antiemetic and oral fluids for all patients presenting with moderate dehydration in primary care. After 60mins, reassess and if insufficient response then give IV fluids + antie...
New Toothache Auckland Regional HealthPathway
February 12, 2020
This new pathway provides guidance on the likely causes of toothache by type of pain and options for pain relief. In addition it discusses the limited role of oral antibiotics, which antibiotics to use, and that intravenous antibiotics are not indicated for dental absc...
Top tips for adult cellulitis management
January 22, 2020
A trial oral Fluclox 1g QID unless : symptomatic PVD, symptomatic venous insufficiency or BMI >40 for all patients presenting with cellulitis in primary care
Discuss all cases for consideration of IVs without a trial of oral antibiotics with the Infectious Diseases team u...
Loading...
TAGS
abscesscellulitisdvtECGRivaroxabanTroponinACSAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScephazolinChest PainclexaneCOVID19CXRcystdehydrationdentalectopicFAQsFerinjectgynaeHep CHepatitisINRIVIV ironmaternityMaviretNurse AdvisorOSTovarianovarian cystovarian torsionpaediatric cellulitispelvic painpelvic scanpelvic ussPIDPOACPOAC ECGpoac pelvic\Sarah Hydersore throattonsilitistoothachewells scoreXray
Loading...